Abstract
Biobanks collect and store human biospecimens, playing a vital role in the
development of novel drugs and diagnostics. In recent years, large
population-based biobanks have been established which monitor the health
status of participants over time to assess the natural occurrence and
progression of common diseases. Hundreds of disease-based biobanks are located
around the world, which are a valuable resource for biomarker discovery as
well as for studying progression, mortality and responses to treatment. - The
Future of Biobanks - is a new report published by Business Insights that
examines major trends in the biobanking industry and identifies the key
initiatives to upgrade the biobanking infrastructure. This report explores the
applications of biobanks and provides examples of how large sets of
high-quality biosamples are creating new ways to diagnose, prevent and treat
diseases. The activities of over 180 US biobanks are assessed to illustrate
how the scale and scope of biobanking is changing. This report also evaluates
the limitations of biobanks, in addition to reviewing the unique legal,
regulatory and ethical issues that surround this new frontier of biomolecular
research.
|